Cancer is a leading cause of death in canines, with 1 in 4 dogs in the u.s Expected to be diagnosed with cancer in their lifetime.² 73% of pet owners are interested in having a cancer screening test for their pet—and now you can offer them one.³ the revolutionary technology behind idexx cancer dx testing detects a proprietary, circulating biomarker. Idexx laboratories shared earlier this month the launch of idexx cancer dx, a diagnostic panel with early detection of lymphoma in canine patients The new panel is an accessible blood test that can be added to the panels of sick pets and can be integrated into annual wellness screenings Idexx cancer dx costs as low as $15, providing professionals in the united states with actionable results. The nu.q canine cancer screening test, a diagnostic product manufactured by volition, is now available through idexx’s u.s
Technology enables affordable inclusion in preventive care profiles. It is most affordable when ordered in select profiles such as the ones listed below
OPEN
